FdaApplication
ANDA 215393
Identifiers
- fda_app_no: ANDA215393
Properties
| Property | Value |
|---|---|
| applicant_name | PADAGIS ISRAEL PHARMACEUTICALS LTD |
| application_type | ANDA |
| approval_date | 2025-07-29 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TAZAROTENE | TAZAROTENE | 0.045% | LOTION;TOPICAL |
1 product